Eris Lifesciences Ltd (NSE:ERIS)
₹ 1042.9 11.1 (1.08%) Market Cap: 141.66 Bil Enterprise Value: 155.44 Bil PE Ratio: 36.17 PB Ratio: 5.48 GF Score: 97/100

Q2 2023 Eris Lifesciences Ltd Earnings Call Transcript

Oct 20, 2022 / 10:30AM GMT
Release Date Price: ₹707.85 (-2.92%)
Operator

Ladies and gentlemen, good day, and welcome to the Q2 and H1 FY '23 Earnings Conference Call of Eris Lifesciences Limited.

We have with us on the call today, Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir.

Krishnakumar Vaidyanathan
Eris Lifesciences Limited - Executive Director & COO

Thank you. Good afternoon, and welcome to our earnings call for the second quarter of financial year '23. I'm Krishnakumar, and I'll be sharing the highlights of this quarter and the first half of the year over you.

Oaknet, our recent acquisition in the month of May 2002 is emerging as a clear success story in value creation through M&A. Oaknet's growth momentum continues with quarter 2 revenue of INR 68 crores and EBITDA of INR 16.5 crores, which

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot